Izrael - hebrejština - Ministry of Health

teva medical marketing ltd. - sodium chloride 9 mg/ml - solution for infusion - sodium chloride - a source of water and electrolytes. also indicated for use as a priming solution in hemodialysis procedures.

Izrael - hebrejština - Ministry of Health

neopharm (israel) 1996 ltd - calcium chloride 27 mg / 100 ml; lactic acid as sodium 0.533 g / 100 ml - solution for injection - combinations of electrolytes - isotonic injectable solution.

Izrael - hebrejština - Ministry of Health

taro pharmaceutical industries ltd - glyceryl trinitrate 1 mg/ml - solution for infusion - glyceryl trinitrate - nitroglycerin is indicated for: 1. control of hypertension during cardiac surgery. 2. unresponsive congestive heart failure associated with acute myocardial infarction. 3. treatment of anginal pectoris in hospitalised patients who have not responded to organic nitrates and/or beta blockers. 4. maintenance of controlles hypotension during surgical procedurs.

Izrael - hebrejština - Ministry of Health

taro pharmaceutical industries ltd - glyceryl trinitrate 1 mg/ml - solution for infusion - glyceryl trinitrate - control of hypertension during cardiac surgery. unresponsive congestive heart failure associated with acute myocardial infarction. treatment of angina pectoris in hospitalised patients who have not responded to organic nitrates and/or beta blockers. maintenance of controlled hypotension during surgical procedures.

Izrael - hebrejština - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - aluminium chlorohydroxide complex solution; methylprednisolone acetate; neomycin sulfate; sulfur - תרחיץ - methylprednisolone acetate 2.5 mg/ml; neomycin sulfate 2.5 mg/ml; sulfur 50 mg/ml; aluminium chlorohydroxide complex solution 200 mg/ml - methylprednisolone - methylprednisolone - acne.

Izrael - hebrejština - Ministry of Health

ferring pharmaceuticals ltd - atosiban - solution for injection - atosiban 7.5 mg/ml - atosiban - atosiban - atosiban is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes - a cervical dilation of 1 to 3 cm (0-3 for iparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate.

Izrael - hebrejština - Ministry of Health

sanofi - aventis israel ltd - plerixafor 24 mg / 1.2 ml - solution for injection - plerixafor - mozobil is indicated in combination with g-csf to enhance mobilisation of haematopietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma .

Izrael - hebrejština - Ministry of Health

kamada ltd - bupivacaine hydrochloride 100 mg / 20 ml - solution for injection - bupivacaine - kamacaine is indicated for the production of local or regional anesthesia or analgesia for surgery, oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. kamacaine is also indicated for spinal anesthesia for surgery.

Izrael - hebrejština - Ministry of Health

kamada ltd - bupivacaine as hydrochloride anhydrous 5 mg / 1 ml - solution for injection - bupivacaine - long acting local anaesthetic.

Izrael - hebrejština - Ministry of Health

salomon,levin & elstein ltd - ropivacaine hydrochloride ( as monohydrate) 2 mg/ml - solution for injection - ropivacaine - surgical anaesthesia: epidural block for surgery, including caesarean section. peripheral nerve blocks and infiltration anaesthesia. acute pain management: continuous epidural infusion or intermittent bolus administration e.g. post operative or labour pain. field block.